Subunit vaccines are safer than live-attenuated or inactivated vaccines. However, their limited immunogenicity and susceptibility to metabolic degradation require strong adjuvants and/or conjugation to delivery systems to induce a robust, antigen-specific immune response. Interestingly, synthetic peptides can be useful and polyvalent building blocks for development of self-adjuvanted nanoparticles. Recent studies showed that amphiphilic peptides can increase antigen density, promote cellular uptake by APCs and activate T and B lymphocytes. Additionally, short peptide monomers forming cross-β-sheet fibrils such as I10 have shown potential in inducing strong immunity against the grafted epitope. However, direct comparison of the intrinsic immunogenicity of peptide amphiphilic cylindrical micelles and cross-β peptide fibrils has never been performed. In this work, the amphiphilic peptide C16-V3A3K3(PA) and the I10 β-peptide were each linked to two epitope models, OVA253-266 and OVA323-339, able to polarize the resulting adaptive immune response differently. Biophysical analysis showed that both nanoplatforms formed β-sheet-rich nanofilament structures with epitopes exposed on their surfaces. Intramuscular administration in mice led to a strong, antigen-specific humoral response without additional adjuvants. This study illuminates the potential of synthetic self-assembling nanoplatforms as universal antigen carriers, enabling the rapid development of vaccines to combat infectious diseases.
We are working on a new version of the website! To complete the upgrade, Sciforum will be unavailable on Saturday 18 July from 09:00 to 15:00 CEST. Thank you for your understanding.
Previous Article in event
Previous Article in session
Next Article in event
Comparative study of the immunogenicity of two synthetic nanovaccines based on self-assembling peptides
Published:
16 November 2024
by MDPI
in 2nd Canadian Peptide and Protein Community Virtual Meeting
session Exploration of nature through the lens of peptides and proteins
Abstract:
Keywords: nanovaccines; adjuvant; peptide self-assembly; immune response; supramolecular structure
